We get inflammation and then we get these plaques that are just big and angry in the heart
[DOI] [PubMed] [Google Scholar] 58.Sinha R, Sinha I, Calcagnotto A, Trushin N, Haley JS, Schell TD, Richie JP
LegroRSKunselmanARMeadowsJWKesnerJSKriegEFRogersAMet al
Tirzepatide is a groundbreaking dual-action medication that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
Despite the potential for side effects, the overall efficacy and safety profile of GLP-1 receptor agonists has made them a cornerstone in modern diabetes and obesity management
Examples of subpopulations include but are not limited to metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), hepatitis B virus (HBV), hepatocellular carcinoma (HCC), primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), cirrhosis, ALPHA 1, alcoholic liver disease (ALD), and Wilson's disease